Mirae Asset Global Investments »

Mineralys Therapeutics shares owned by Mirae Asset Global Investments

Quarter-by-quarter ownership of Mineralys Therapeutics (MLYS) shares owned by Mirae Asset Global Investments from 13F filings

Historical chart of Mirae Asset Global Investments investment in Mineralys Therapeutics

Jul 2024Aug 2024Sep 2024Oct 2024Nov 2024Dec 2024Jan 202517k18k19k20k21k1500160017001800
Value ($)Share countHistorical MLYS position of Mirae Asset Global … Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Mineralys Therapeutics held by Mirae Asset Global Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mineralys Therapeutics by Mirae Asset Global Investments

Quarter filed Position value Share count Share price at filing
2024-12-31 $21k 1.7k 12.82
2024-09-30 $21k 1.8k 11.90
2024-06-30 $17k 1.5k 11.50

More positions owned by Mirae Asset Global Investments

NVIDIA Corporation (NVDA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Tesla Motors (TSLA)
Ishares Tr Core S&p500 Etf (IVV)
Meta Platforms Cl A (META)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Invesco Exch Traded Fd Tr Ii Nasdaq 100 Etf (QQQM)
Eli Lilly & Co. (LLY)

View all positions for Mirae Asset Global Investments

Top funds holding Mineralys Therapeutics

Catalys Pacific
Samsara BioCapital
RA Capital Management
TCG Crossover Management
BlackRock
Sr One Capital Management
Franklin Resources
OrbiMed Advisors
Vanguard Group
Laurion Capital Management
Adams Street Partners
Millennium Management
Jennison Associates
Caligan Partners
Integral Health Asset Management

View all funds holding Mineralys Therapeutics